Advertisement

PharmacoEconomics & Outcomes News

, Volume 842, Issue 1, pp 5–5 | Cite as

Assessing treatments for stage III/IV melanoma in Ireland

Meeting report
  • 4 Downloads

References

  1. 1.
    Gorry C, et al. Economic Evaluation of Checkpoint Inhibitors for the Treatment of Advanced Melanoma in the Irish Healthcare Setting. 22nd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PCN184, 2 Nov 2019. Available from: URL: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3119/97750
  2. 2.
    Gorry C, et al. Economic Evaluation of Targeted Treatments for Brafv600 Positive Melanoma in the Irish Healthcare Setting. 22nd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research : abstr. PCN73, 2 Nov 2019. Available from: URL: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3119/97421
  3. 3.
    Gorry C, et al. Potential Budget Impact of Adjuvant Treatments for Stage III Melanoma in Ireland. 22nd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PCN240, 2 Nov 2019. Available from: URL: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3119/95704

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations